Hans Glaumann

9.2k total citations · 1 hit paper
210 papers, 7.3k citations indexed

About

Hans Glaumann is a scholar working on Epidemiology, Molecular Biology and Hepatology. According to data from OpenAlex, Hans Glaumann has authored 210 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Epidemiology, 43 papers in Molecular Biology and 38 papers in Hepatology. Recurrent topics in Hans Glaumann's work include Liver Disease Diagnosis and Treatment (34 papers), Pharmacogenetics and Drug Metabolism (31 papers) and Autophagy in Disease and Therapy (25 papers). Hans Glaumann is often cited by papers focused on Liver Disease Diagnosis and Treatment (34 papers), Pharmacogenetics and Drug Metabolism (31 papers) and Autophagy in Disease and Therapy (25 papers). Hans Glaumann collaborates with scholars based in Sweden, United States and Norway. Hans Glaumann's co-authors include Louis Marzella, F J Ballard, Jan L. E. Ericsson, J Ahlberg, Gustav Dallner, Annika Bergquist, Greger Lindberg, Birgitta Strandvik, Ulrika Broomé and Rolf Hultcrantz and has published in prestigious journals such as Science, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Hans Glaumann

203 papers receiving 6.9k citations

Hit Papers

Decreased Survival of Subjects With Elevated Liver Functi... 2009 2026 2014 2020 2009 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans Glaumann Sweden 46 2.7k 1.9k 1.6k 1.4k 1.0k 210 7.3k
Maria Eugenia Guicciardi United States 34 2.9k 1.1× 3.2k 1.7× 1.3k 0.8× 1.1k 0.8× 934 0.9× 61 7.1k
Dean J. Tuma United States 51 2.7k 1.0× 2.5k 1.3× 722 0.5× 714 0.5× 1.4k 1.4× 261 8.3k
Maurizio Parola Italy 54 4.4k 1.6× 3.1k 1.6× 3.9k 2.5× 1.5k 1.1× 780 0.8× 167 10.5k
Nancy L. R. Bucher United States 47 1.8k 0.7× 4.1k 2.2× 2.4k 1.6× 2.3k 1.6× 706 0.7× 67 8.2k
Irwin M. Arias United States 58 1.1k 0.4× 4.4k 2.3× 815 0.5× 2.0k 1.4× 895 0.9× 196 10.0k
Matías A. Ávila Spain 58 2.4k 0.9× 4.9k 2.6× 1.8k 1.1× 1.2k 0.9× 564 0.6× 220 9.8k
Jordi Muntané Spain 43 1.6k 0.6× 2.3k 1.2× 734 0.5× 1.1k 0.8× 440 0.4× 167 5.9k
Harmeet Malhi United States 49 5.2k 1.9× 3.5k 1.9× 2.5k 1.6× 2.1k 1.5× 2.1k 2.0× 113 10.1k
Hidekazu Tsukamoto United States 73 7.8k 2.9× 5.4k 2.9× 4.3k 2.8× 2.1k 1.5× 1.2k 1.2× 209 16.6k
Sang Geon Kim South Korea 56 1.5k 0.6× 5.4k 2.9× 578 0.4× 701 0.5× 692 0.7× 241 9.4k

Countries citing papers authored by Hans Glaumann

Since Specialization
Citations

This map shows the geographic impact of Hans Glaumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Glaumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Glaumann more than expected).

Fields of papers citing papers by Hans Glaumann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Glaumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Glaumann. The network helps show where Hans Glaumann may publish in the future.

Co-authorship network of co-authors of Hans Glaumann

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Glaumann. A scholar is included among the top collaborators of Hans Glaumann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Glaumann. Hans Glaumann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zimmer, Christine L., Iva Filipovic, Martin Cornillet, et al.. (2021). Mucosal‐associated invariant T‐cell tumor infiltration predicts long‐term survival in cholangiocarcinoma. Hepatology. 75(5). 1154–1168. 26 indexed citations
2.
Hollander, A. Gerson, Hans Glaumann, & Ola Weiland. (2004). Histological findings, genotype distribution and percentage of patients fulfilling the treatment criteria among patients with chronic hepatitis C virus infection in a single Swedish centre. Scandinavian Journal of Gastroenterology. 39(2). 164–167. 6 indexed citations
3.
Sällberg, Matti, et al.. (2000). The GB Virus C/Hepatitis G Virus Replicates in Hepatocytes without Causing Liver Disease in Healthy Blood Donors. The Journal of Infectious Diseases. 182(6). 1756–1760. 14 indexed citations
4.
Bergquist, Annika, Bernhard Tribukait, Hans Glaumann, & Ulrika Broomé. (2000). Can DNA cytometry be used for evaluation of malignancy and premalignancy in bile duct strictures in primary sclerosing cholangitis?. Journal of Hepatology. 33(6). 873–877. 46 indexed citations
5.
Broomé, Ulrika, et al.. (1994). Liver disease in ulcerative colitis: an epidemiological and follow up study in the county of Stockholm.. Gut. 35(1). 84–89. 107 indexed citations
6.
Glaumann, Hans, et al.. (1992). Intracellular distribution and effect of the antimalarial drug mefloquine on lysosomes of rat liver. Liver International. 12(4). 183–190. 19 indexed citations
7.
Schvarcz, Robert, Hans Glaumann, Ola Weiland, et al.. (1991). Interferon alpha-2b treatment of chronic posttransfusion non-A, non-B/C hepatitis: Long-term outcome and effect of increased interferon doses in non-responders. Scandinavian Journal of Infectious Diseases. 23(4). 413–420. 15 indexed citations
8.
Broomé, Ulrika, Hans Glaumann, & R. Hultcrantz. (1990). Liver histology and follow up of 68 patients with ulcerative colitis and normal liver function tests.. Gut. 31(4). 468–472. 25 indexed citations
9.
Broomé, Ulrika, Hans Glaumann, R. Hultcrantz, & Urban Forsum. (1990). Distribution of HLA-DR, HLA-DP, HLA-DQ Antigens in Liver Tissue from Patients with Primary Sclerosing Cholangitis. Scandinavian Journal of Gastroenterology. 25(1). 54–58. 53 indexed citations
11.
Stål, Per, Hans Glaumann, & Rolf Hultcrantz. (1990). Liver cell damage and lysosomal iron storage in patients with idiopathic hemochromatosis. Journal of Hepatology. 11(2). 172–180. 35 indexed citations
12.
Glaumann, Hans, et al.. (1989). Overall proteolysis in perfused and subfractionated chemically induced malignant hepatoma of rat: Effects of amino acids. Experimental and Molecular Pathology. 50(1). 38–49. 8 indexed citations
13.
Glaumann, Hans, et al.. (1989). Isolation and characterization of crinosomes—A subclass of secondary lysosomes. Experimental and Molecular Pathology. 50(2). 167–182. 6 indexed citations
14.
Lindh, Gudrun, Ola Weiland, & Hans Glaumann. (1988). The application of a numerical scoring system for evaluating the histological outcome in patients with chronic hepatitis B followed in long term. Hepatology. 8(1). 98–103. 19 indexed citations
15.
Schvarcz, Robert, Ola Weiland, & Hans Glaumann. (1988). Alpha Interferon Treatment of Chronic Non-A, Non-B Hepatitis Caused by Intravenous Gammaglobulin. Scandinavian Journal of Infectious Diseases. 20(2). 231–232. 9 indexed citations
16.
Strandvik, Birgitta, Lena Hjelte, N. Gabrielsson, & Hans Glaumann. (1988). Sclerosing Cholangitis in Cystic Fibrosis. Scandinavian Journal of Gastroenterology. 23(sup143). 121–124. 34 indexed citations
17.
Glaumann, Hans & F J Ballard. (1987). Lysosomes : their role in protein breakdown. Academic Press eBooks. 381 indexed citations
18.
Pacifici, G. M., et al.. (1985). Isolation of Nuclear Fractions from Human Fetal Tissues. Pharmacology. 30(4). 188–196. 6 indexed citations
19.
Glaumann, Hans, Theodore Peters, & Colvin M. Redman. (1983). Plasma protein secretion by the liver. Academic Press eBooks. 146 indexed citations
20.
Glaumann, Hans, Robert Nilsson, & Gustav Dallner. (1970). Cytoplasmic location of certain small molecules after their metabolism by the endoplasmic reticulum of rat liver. FEBS Letters. 10(5). 306–308. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026